Kidney Disease Clinical Trials in Chicago

Showing 301-320 of 407 trials

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

NCT01907802

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

BRAF Gene MutationHepatic ComplicationRenal Failure+1 more

National Cancer Institute (NCI)8 participantsStarted Aug 2013

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

COMPLETEDPhase 32.2 miles

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01473420

The purpose of this study is to demonstrate therapeutic equivalence of subcutaneous (SC) Epoetin Hospira compared to SC Epogen (Amgen), based on maintenance of hemoglobin (Hb) levels and study drug dose requirements in patients treated for anemia associated with chronic renal failure and on hemodialysis.

Chronic Renal FailureChronic Kidney Disease

Pfizer320 participantsStarted Jan 2012

Azusa, California, United States • Bakersfield, California, United States • Long Beach, California, United States +70 more locations

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Kidney Disease Trials in Other Cities

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Exercise in Obese Diabetic Patients With Chronic Kidney Disease

A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

VEG111485: A QTc Study of Pazopanib

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Study Of Palbociclib (PD-0332991) In Renal Impairment

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Other Conditions in Chicago